1. Academic Validation
  2. Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin

Antimalarial acridines: synthesis, in vitro activity against P. falciparum and interaction with hematin

  • Bioorg Med Chem. 2009 Dec 1;17(23):8032-9. doi: 10.1016/j.bmc.2009.10.005.
Lucie Guetzoyan 1 Xiao-Min Yu Florence Ramiandrasoa Stéphanie Pethe Christophe Rogier Bruno Pradines Thierry Cresteil Martine Perrée-Fauvet Jean-Pierre Mahy
Affiliations

Affiliation

  • 1 Equipe de Chimie Bioorganique et Bioinorganique, Institut de Chimie Moléculaire et des Matériaux d'Orsay, Bât. 420, CNRS UMR 8182, Univ Paris-Sud, 91405 Orsay Cedex, France.
Abstract

A series of acridine derivatives were synthesised and their in vitro antimalarial activity was evaluated against one chloroquine-susceptible strain (3D7) and three chloroquine-resistant strains (W2, Bre1 and FCR3) of Plasmodium falciparum. Structure-activity relationship showed that two positives charges as well as 6-chloro and 2-methoxy substituents on the acridine ring were required to exert a good antimalarial activity. The best compounds possessing these features inhibited the growth of the chloroquine-susceptible strain with an IC(50)0.07 microM, close to that of chloroquine itself, and that of the three chloroquine-resistant strains better than chloroquine with IC(50)0.3 microM. These acridine derivatives inhibited the formation of beta-hematin, suggesting that, like CQ, they act on the haem crystallization process. Finally, in vitro cytotoxicity was also evaluated upon human KB cells, which showed that one of them 9-(6-ammonioethylamino)-6-chloro-2-methoxyacridinium dichloride 1 displayed a promising antimalarial activity in vitro with a quite good selectivity index versus mammalian cell on the CQ-susceptible strain and promising selectivity on Other strains.

Figures